Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00501579 · ClinicalTrials.gov registry record · Phase 3
Study of Difluprednate in the Treatment of Uveitis
A Phase 3 study of Uveitis, sponsored by Sirion Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 1
- Study location
NCT00501579 is a Phase 3 study of Uveitis that has completed, run by Sirion Therapeutics. The trial reports 1 study location across 1 state.
The verdict
NCT00501579, a Phase 3 study of Uveitis, has completed, sponsored by Sirion Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1
- Study location
Study Summary
The purpose of this study is to determine the safety and efficacy of difluprednate compared with prednisolone acetate in the treatment of endogenous anterior uveitis.
Conditions Studied
Interventions
- DRUG Difluprednate
- DRUG Prednisolone Acetate
Study Locations (1)
Indiana
- John-Kenyon American Eye Institute - New Albany
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00501579
The ClinicalTrials.gov registry entry for NCT00501579 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Sirion Therapeutics, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Uveitis appearing as the primary indexed condition, and to 2 interventions - of which Difluprednate is the first listed.
NCT00501579 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT00501579 about?
NCT00501579 is a clinical study titled "Study of Difluprednate in the Treatment of Uveitis". The purpose of this study is to determine the safety and efficacy of difluprednate compared with prednisolone acetate in the treatment of endogenous anterior uveitis.
What is the current status of trial NCT00501579?
This trial is currently completed. It is a Phase 3 study.
What conditions does trial NCT00501579 study?
This clinical trial studies the following conditions: Uveitis.
What interventions are being tested in trial NCT00501579?
The interventions under investigation include: Difluprednate (DRUG), Prednisolone Acetate (DRUG).
Who is sponsoring clinical trial NCT00501579?
This trial is sponsored by Sirion Therapeutics, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00501579 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uveitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment
RECRUITING · Phase 3
-
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
ACTIVE NOT RECRUITING · Phase 3
-
Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis
COMPLETED · Phase 3
-
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
COMPLETED · Phase 3
-
Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial
COMPLETED · Phase 3
-
RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.